Methods to detect P-glycoprotein and implications for other drug resistance-associated proteins

Leukemia

Volumn 11, Issue 7, 1997, Pages 1107-1109

  Beck, W T ^a   Grogan, T M ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Clinical; Detection; Immunostaining; Methods; P glycoprotein; Tumors

Indexed keywords

GLYCOPROTEIN P;

ARTICLE; ASSAY; HUMAN; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; STANDARDIZATION; TUMOR;

EID: 0030739541     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400675     Document Type: Article

References (18)

1. Ueda K, Carderelli C, Gottesman MM, Pastan I. Expression of a full length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 1987; 84: 3004-3008.
2. Grant CE, Valdimarsson G, Hipfner DR, Almquist KC, Cole SP, Deeley RG. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994; 54: 357-361.
3. Kim R, Beck WT. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-16. Cancer Res 1994; 54: 4958-4966.
4. O'Connor PM, Ferris DK, Pagano M, Draetta G, Pines J, Hunter T, Longo DL, Kohn KW. G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. J Biol Chem 1993; 268: 8298-8308.
5. L can confer a multidrug resistance phenotype. Blood 1995; 86: 1903-1910.
6. Scheffer GL, Wijngaard PLJ, Flens MJ, Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJLM, Clevers HC, Scheper RJ. The drug resistance related protein LRP is a major vault protein. Nature Med 1995; 1: 578-582.
7. Kapoor R, Slade DL, Fujimori A, Pommier Y, Harker WG. Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecin. Oncol Res 1995; 7: 83-95.
8. Beck WT. DNA topoisomerases and tumor cell resistance to their inhibitors. In: Shilsky R, Milano G, Ratain M (eds). Principles of Antineoplastic Drug Development and Pharmacology. Marcel Dekker: New York, 1996, pp 487-501.
9. Trent JM, Buick RN, Olson S, Horns RC Jr, Schimke RT. Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma. J Clin Oncol 1984; 2: 8-15.
10. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 1990; 50: 6119-6129.
11. Beck WT, Grogan T, Willman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, Andreeff M, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxterman HJ, Chan HSL, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Houghton PJ, Srivastava DK, Lehnert M, Leith CP, Paietta E, Pavelic ZP, Rimsza L, Roninson IB, Sikic BI, Twentyman PR, Warnke R, Weinstein R. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res 1996; 56: 3010-3020.
12. Chan HSL, Thorner PS, Haddad G, Ling V. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 1990; 8: 689-704.
13. Kuttesch JF, Parham DM, Luo X, Meyer WH, Bowman L, Shapiro DN, Pappo AS, Crist WM, Beck WT, Houghton PJ. P-glycoprotein expression at diagnosis does not correlate with response or out-come in childhood rhabdomyosarcoma. J Clin Oncol 1996; 14: 886-900.
14. Broxterman HJ, Feller N, Kuiper CM, Boven E, Versantvoort CHM, Teerlink T, Pinedo HM, Lankelma J. Correlation between functional and molecular analysis of mdr1 P-glycoprotein in human solid-tumor xenografts. Int J Cancer 1995; 61: 880-886.
15. Leith CP, Chen I-M, Kopecky KJ, Appelbaum FR, Head DR, Godwin JE, Weick JK, Willman CL. Correlation of multidrug resistance protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases. Blood 1995; 86: 2329-2342.
16. Brophy NA, Marie JP, Rojas VA, Warnke RA, McFall PH, Smith SD, Sikic BI. Mdr1 gene expression in childhood acute lymphoblastic leukemias and lymphomas: a critical evaluation by four techniques. Leukemia 1994; 8: 327-335.
17. Zhou DC, Zittoun R, Marie JP. Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia. Leukemia 1995; 9: 1661-1666.
18. Sikic BI. Modulation of multidrug resistance: at the threshold. J Clin Oncol 1993; 11: 1629-1635.